Deletion of c-FLIP from CD11bhi Macrophages Prevents Development of Bleomycin-induced Lung Fibrosis
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Idiopathic pulmonary fibrosis is a progressive lung disease with complex pathophysiology and fatal prognosis. Macrophages (MΦ) contribute to the development of lung fibrosis; however, the underlying mechanisms and specific MΦ subsets involved remain unclear. During lung injury, two subsets of lung MΦ coexist: Siglec-Fhi resident alveolar MΦ and a mixed population of CD11bhi MΦ that primarily mature from immigrating monocytes. Using a novel inducible transgenic system driven by a fragment of the human CD68 promoter, we targeted deletion of the antiapoptotic protein cellular FADD-like IL-1β–converting enzyme–inhibitory protein (c-FLIP) to CD11bhi MΦ. Upon loss of c-FLIP, CD11bhi MΦ became susceptible to cell death. Using this system, we were able to show that eliminating CD11bhi MΦ present 7–14 days after bleomycin injury was sufficient to protect mice from fibrosis. RNA-seq analysis of lung MΦ present during this time showed that CD11bhi MΦ, but not Siglec-Fhi MΦ, expressed high levels of profibrotic chemokines and growth factors. Human MΦ from patients with idiopathic pulmonary fibrosis expressed many of the same profibrotic chemokines identified in murine CD11bhi MΦ. Elimination of monocyte-derived MΦ may help in the treatment of fibrosis. We identify c-FLIP and the associated extrinsic cell death program as a potential pathway through which these profibrotic MΦ may be pharmacologically targeted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“depletion of Mo-AMs via several strategies conferred protection from lung fibrosis in multiple mouse models1,3,10,11,13,20”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The pathogenic role of Mo-AMs in lung fibrosis has been largely attributed to their activity in producing a number of pro-fibrotic mediators, such as TGF-β, PDGF-α, osteopontin (OPN), and MMPs1,3,11,13,15,18,28.”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [11]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689
Hashimoto, D., Chow, A., Noizat, C., Teo, P., Beasley, M. B., Leboeuf, M., Becker, C. D., See, P., Price, J., Lucas, D., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.004 · Cited by 2,311
Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Xue, J., Schmidt, S. V., Sander, J., Draffehn, A., Krebs, W., Quester, I., De Nardo, D., Gohel, T. D., Emde, M., Schmidleithner, L., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.006 · Cited by 2,210
Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment
Lavin, Y., Winter, D., Blecher-Gonen, R., David, E., Keren-Shaul, H., Merad, M., Jung, S., & Amit, I. (2014) · Cell · doi:10.1016/j.cell.2014.11.018 · Cited by 2,167
the Immunological Genome Consortium, Gautier, E. L., Shay, T., Miller, J., Greter, M., Jakubzick, C., Ivanov, S., Helft, J., Chow, A., Elpek, K. G., et al. (2012) · Nature Immunology · doi:10.1038/ni.2419 · Cited by 1,972
Self-citationOrigin and functions of tissue macrophages
Epelman, S., Lavine, K. J., & Randolph, G. J. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.013 · Cited by 1,585
Guilliams, M., De Kleer, I., Henri, S., Post, S., Vanhoutte, L., De Prijck, S., Deswarte, K., Malissen, B., Hammad, H., & Lambrecht, B. N. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20131199 · Cited by 1,276
Tsou, C.-L., Peters, W., Si, Y., Slaymaker, S., Aslanian, A. M., Weisberg, S. P., Mack, M., & Charo, I. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29919 · Cited by 1,152
Fibroblasts in fibrosis: novel roles and mediators
Kendall, R. T., & Feghali-Bostwick, C. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00123 · Cited by 1,082
Flow Cytometric Analysis of Macrophages and Dendritic Cell Subsets in the Mouse Lung
Misharin, A. V., Morales-Nebreda, L., Mutlu, G. M., Budinger, G. R. S., & Perlman, H. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0086ma · Cited by 838
Cited by
Reyfman, P. A., Walter, J. M., Joshi, N., Anekalla, K. R., McQuattie-Pimentel, A. C., Chiu, S., Fernandez, R., Akbarpour, M., Chen, C.-I., Ren, Z., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2410oc · Cited by 1,203
“In that system, we showed that selective genetic deletion of monocytederived alveolar macrophages while leaving tissue-resident alveolar macrophages intact resulted in improved fibrosis, a finding that has been subsequently confirmed by an independent group (35).”
BackgroundResultThe role of macrophages in the resolution of inflammation
Watanabe, S., Alexander, M., Misharin, A. V., & Budinger, G. R. S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124615 · Cited by 925
“More importantly, in patients with pulmonary fibrosis, single-cell RNA-Seq demonstrated heterogeneity in macrophage phenotypes in patients with fibrosis relative to controls, and spatial transcriptomics confirmed that “profibrotic” macrophages coexist with “normal” macrophages in the same microenvironment, supporting…”
BackgroundProliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis
Morse, C., Tabib, T., Sembrat, J., Buschur, K. L., Bittar, H. T., Valenzi, E., Jiang, Y., Kass, D. J., Gibson, K., Chen, W., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.02441-2018 · Cited by 822
Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
Moss, B. J., Ryter, S. W., & Rosas, I. O. (2022) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-042320-030240 · Cited by 821
Biology of lung macrophages in health and disease
Aegerter, H., Lambrecht, B. N., & Jakubzick, C. V. (2022) · Immunity · doi:10.1016/j.immuni.2022.08.010 · Cited by 621
Self-citationMacrophages in Lung Injury, Repair, and Fibrosis
Cheng, P., Li, S., & Chen, H. (2021) · Cells · doi:10.3390/cells10020436 · Cited by 444
Macrophage polarization and allergic asthma
Saradna, A., Do, D. C., Kumar, S., Fu, Q.-L., & Gao, P. (2018) · Translational Research · doi:10.1016/j.trsl.2017.09.002 · Cited by 424
Cui, H., Xie, N., Banerjee, S., Ge, J., Jiang, D., Dey, T., Matthews, Q. L., Liu, R.-M., & Liu, G. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0360oc · Cited by 367
Joshi, N., Watanabe, S., Verma, R., Jablonski, R. P., Chen, C.-I., Cheresh, P., Markov, N. S., Reyfman, P. A., McQuattie-Pimentel, A. C., Sichizya, L., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00646-2019 · Cited by 344
Joshi, N., Walter, J. M., & Misharin, A. V. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.01.005 · Cited by 307
Role of Macrophages in Acute Lung Injury and Chronic Fibrosis Induced by Pulmonary Toxicants
Laskin, D. L., Malaviya, R., & Laskin, J. D. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfy309 · Cited by 267
Bain, C. C., & MacDonald, A. S. (2022) · Mucosal Immunology · doi:10.1038/s41385-021-00480-w · Cited by 255
Mansouri, N., Willis, G. R., Fernandez-Gonzalez, A., Reis, M., Nassiri, S., Mitsialis, S. A., & Kourembanas, S. (2019) · JCI Insight · doi:10.1172/jci.insight.128060 · Cited by 237
Diversity of Macrophages in Lung Homeostasis and Diseases
Hou, F., Xiao, K., Tang, L., & Xie, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.753940 · Cited by 214
Distinct developmental pathways from blood monocytes generate human lung macrophage diversity
Evren, E., Ringqvist, E., Tripathi, K. P., Sleiers, N., Rives, I. C., Alisjahbana, A., Gao, Y., Sarhan, D., Halle, T., Sorini, C., et al. (2021) · Immunity · doi:10.1016/j.immuni.2020.12.003 · Cited by 185
“Cluster 6 macrophages had high expression of genes encoding chemo-kines ( CCL2 , CCL4 , CCL8 , CXCL10 , CXCL11 ) and the pro-in-flammatory cytokine IL1B , similar to mouse interstitial macrophages (McCubbrey et al., 2018; Sajti et al., 2020; Schyns et al., 2019).”
The lung microenvironment shapes a dysfunctional response of alveolar macrophages in aging
McQuattie-Pimentel, A. C., Ren, Z., Joshi, N., Watanabe, S., Stoeger, T., Chi, M., Lu, Z., Sichizya, L., Aillon, R. P., Chen, C.-I., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci140299 · Cited by 177
“We and others have reported that deletion of MoAMs attenuates the severity of both bleomycin-induced lung fibrosis and influenza A virus–induced pneumonia (8, 26, 38).”
BackgroundMethodOrigin and ontogeny of lung macrophages: from mice to humans
Evren, E., Ringqvist, E., & Willinger, T. (2020) · Immunology · doi:10.1111/imm.13154 · Cited by 172
Regulation of epithelial transitional states in murine and human pulmonary fibrosis
Wang, F., Ting, C., Riemondy, K. A., Douglas, M., Foster, K., Patel, N., Kaku, N., Linsalata, A., Nemzek, J., Varisco, B. M., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci165612 · Cited by 162
Self-citationAlveolar and lung interstitial macrophages: Definitions, functions, and roles in lung fibrosis
Shi, T., Denney, L., An, H., Ho, L., & Zheng, Y. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ru0720-418r · Cited by 156
Airspace Macrophages and Monocytes Exist in Transcriptionally Distinct Subsets in Healthy Adults
Mould, K. J., Moore, C. M., McManus, S. A., McCubbrey, A. L., McClendon, J. D., Griesmer, C. L., Henson, P. M., & Janssen, W. J. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202005-1989oc · Cited by 133
Self-citationGünsel, G. G., Conlon, T. M., Jeridi, A., Kim, R., Ertüz, Z., Lang, N. J., Ansari, M., Novikova, M., Jiang, D., Strunz, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28809-4 · Cited by 144
Advances in the management of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
Liu, G. Y., Budinger, G. R. S., & Dematte, J. E. (2022) · BMJ · doi:10.1136/bmj-2021-066354 · Cited by 144
Immune mechanisms in fibrotic interstitial lung disease
Kamiya, M., Carter, H. M., Espíndola, M. S., Doyle, T. J., Lee, J. S., Merriam, L. T., Zhang, F., Kawano-Dourado, L. B., Sparks, J. A., Hogaboam, C. M., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.015 · Cited by 141
Cui, H., Banerjee, S., Guo, S., Xie, N., Ge, J., Jiang, D., Zörnig, M., Thannickal, V. J., & Liu, G. (2019) · JCI Insight · doi:10.1172/jci.insight.124522 · Cited by 132
“Mouse alveolar macrophages (AMs) were isolated as previously described with some modifications (32, 49, 50).”
An SFTPC BRICHOS mutant links epithelial ER stress and spontaneous lung fibrosis
Katzen, J. B., Wagner, B. D., Venosa, A., Kopp, M. C., Tomer, Y., Russo, S. J., Headen, A. C., Basil, M. C., Stark, J. M., Mulugeta, S., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126125 · Cited by 137
Chemokine Receptor 2–targeted Molecular Imaging in Pulmonary Fibrosis. A Clinical Trial
Brody, S. L., Gunsten, S. P., Luehmann, H. P., Sultan, D. H., Hoelscher, M., Heo, G. S., Pan, J., Koenitzer, J. R., Lee, E. C., Huang, T., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202004-1132oc · Cited by 125
Mohning, M. P., Downey, G. P., Cosgrove, G. P., & Redente, E. F. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54431-3.00003-2 · Cited by 123
Self-citationOgawa, T., Shichino, S., Ueha, S., & Matsushima, K. (2021) · International Immunology · doi:10.1093/intimm/dxab040 · Cited by 122
Teaching Old Dogs New Tricks? The Plasticity of Lung Alveolar Macrophage Subsets
Kulikauskaite, J., & Wack, A. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.08.008 · Cited by 119
“that BM-derived AMs provide protection against murine house dust mite (HDM)-induced asthma [11] or can be a driving force for lung fibrosis following mouse lung injury [12,30,31].”
BackgroundMcCubbrey, A. L., Allison, K. C., Lee-Sherick, A. B., Jakubzick, C. V., & Janssen, W. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01618 · Cited by 114
“4), Siglec-F (BD/ E50-2440), CD11c (eBioscience/N418), CD11b (eBioscience/ M1/70), CD103 (eBioscience/2E7), CD115 (eBioscience/ AFS98), CD64 (Biolegend/X54-5/7.1), MerTK (R&D/BAF591), CD3 (Biolegend/17A2), CD19 (eBioscience/eBio1D3), NK1.”
BackgroundInfluentialSelf-citationLocalization of Macrophages in the Human Lung via Design-based Stereology
Hume, P. S., Gibbings, S. L., Jakubzick, C., Tuder, R. M., Curran‐Everett, D., Henson, P. M., Smith, B. J., & Janssen, W. J. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201911-2105oc · Cited by 109
Self-citationNanoparticle targeting of de novo profibrotic macrophages mitigates lung fibrosis
Singh, A., Chakraborty, S., Wong, S. W., Hefner, N. A., Stuart, A., Qadir, A. S., Mukhopadhyay, A., Bachmaier, K., Shin, J.-W., Rehman, J., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2121098119 · Cited by 107
“Transcriptomic and gene-expression analysis revealed that Mo-Macs displayed not only down-regulation of genes typically expressed in monocytes and up-regulation of genes expressed in AMs, but also markedly increased the expression of proinflammatory and profibrotic genes (11, 17, 19).”
BackgroundWatanabe, S., Markov, N. S., Lu, Z., Piseaux Aillon, R., Soberanes, S., Runyan, C. E., Ren, Z., Grant, R. A., Maciel, M., Abdala-Valencia, H., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2101100118 · Cited by 96
Chiang, G. C., & Parimon, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032405 · Cited by 103
“For instance, a pre-clinical study suggests that alveolar cell injury activates inflammation and monocyte-derived macrophages, which drive lung fibrosis [52].”
BackgroundDiverse Injury Pathways Induce Alveolar Epithelial Cell CCL2/12, Which Promotes Lung Fibrosis
Yang, J., Agarwal, M., Ling, S., Teitz‐Tennenbaum, S., Zemans, R. L., Osterholzer, J. J., Sisson, T. H., & Kim, K. K. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0297oc · Cited by 96
Liu, S.-S., Lv, X.-X., Liu, C., Qi, J., Li, Y.-X., Wei, X.-P., Li, K., Hua, F., Cui, B., Zhang, X., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.014 · Cited by 95
Redente, E. F., Aguilar, M., Black, B. P., Edelman, B., Bahadur, A. N., Humphries, S. M., Lynch, D. A., Wollin, L., & Riches, D. W. H. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00304.2017 · Cited by 95
Self-citationThe role of lung macrophages in acute respiratory distress syndrome
Dang, W., Tao, Y., Xu, X., Zhao, H., Zou, L., & Li, Y. (2022) · Inflammation Research · doi:10.1007/s00011-022-01645-4 · Cited by 93
“MDMs apoptosis promotes inflammation resolution and attenuates pulmonary fibrosis [28, 35, 67, 68].”
BackgroundBailey, J. I., Puritz, C. H., Senkow, K. J., Markov, N. S., Diaz, E., Jonasson, E., Yu, Z., Swaminathan, S., Lu, Z., Fenske, S. W., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01975-x · Cited by 85
“Improved physiological outcomes when monocyte-derived alveolar macrophages are specifically deleted, including after bleomycin-and asbestos-induced pulmonary fibrosis 4,5,7 and viral pneumonia 6,8 in mice, indicate a causal role for these cells in lung injury and fibrosis.”
BackgroundThe spatial and temporal activation of macrophages during fibrosis
Behmoaras, J. V., Mulder, K., Ginhoux, F., & Petretto, E. G. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01186-x · Cited by 86
Monocyte-derived alveolar macrophage apolipoprotein E participates in pulmonary fibrosis resolution
Cui, H., Jiang, D., Banerjee, S., Xie, N., Kulkarni, T., Liu, R.-M., Duncan, S. R., & Liu, G. (2020) · JCI Insight · doi:10.1172/jci.insight.134539 · Cited by 82
“Similar transcriptional heterogeneity has also been found in AMs from idiopathic pulmonary fibrosis (IPF) patients (14, 16).”
BackgroundCooley, J. C., Javkhlan, N., Wilson, J. A., Foster, D. G., Edelman, B., Ortiz, L. A., Schwartz, D. A., Riches, D. W. H., & Redente, E. F. (2023) · JCI Insight · doi:10.1172/jci.insight.163762 · Cited by 83
Self-citationTRPV4 Protects the Lung from Bacterial Pneumonia via MAPK Molecular Pathway Switching
Scheraga, R. G., Abraham, S., Grove, L. M., Southern, B. D., Crish, J. F., Perelas, A., McDonald, C., Asosingh, K., Hasday, J. D., & Olman, M. A. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901033 · Cited by 80
Leach, S. M., Gibbings, S. L., Tewari, A., Atif, S. M., Vestal, B. E., Danhorn, T., Janssen, W. J., Wager, T. D., & Jakubzick, C. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108337 · Cited by 79
“But during inflammation, monocytes can differentiate into inflammatory and resolving macrophages, which display distinct properties from resident macrophages (Mould et al., 2017, Mould et al., 2019, McCubbrey et al., 2018, Misharin et al., 2017).”
BackgroundSelf-citationGu, Y., Lawrence, T., Mohamed, R., Liang, Y., & Yahaya, B. H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.923235 · Cited by 77
“Previous studies suggest that monocyte-derived AMs may be involved in fibrosis formation through their interactions with fibroblasts (53).”
ResultTREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity
Cui, H., Banerjee, S., Xie, N., Hussain, M., Jaiswal, A., Liu, H., Kulkarni, T., Antony, V. B., Liu, R.-M., Colonna, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57024-0 · Cited by 74
“The pathogenic role of Mo-AMs in lung fi brosis has been largely attributed to their activity in producing a number of pro-fi brotic mediators, such as TGF-β , PDGF-α , osteopontin (OPN), and MMPs 1,3,11,13,15,18,28 .”
InfluentialMonocyte-derived Alveolar Macrophages: The Dark Side of Lung Repair?
McQuattie‐Pimentel, A. C., Budinger, G. R. S., & Ballinger, M. N. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0328ed · Cited by 72
Mia, M. M., Ghani, S. A. B. A., Cibi, D. M., Bogireddi, H., Nilanthi, U., Selvan, A., Shiu, W., & Singh, M. K. (2025) · European Respiratory Journal · doi:10.1183/13993003.01544-2023 · Cited by 73
Cell Cross-Talk in Alveolar Microenvironment: From Lung Injury to Fibrosis
Song, L., Li, K., Chen, H., & Xie, L. (2024) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2023-0426tr · Cited by 71
“Reducing the population of monocyte-derived macrophages can alleviate bleomycin-induced pulmonary fi brosis (102, 107, 108).”
BackgroundA Novel CD206 Targeting Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice
Ghebremedhin, A., Salam, A. B., Adu-Addai, B., Noonan, S., Stratton, R. J., Ahmed, M. S. U., Khantwal, C. M., Martin, G. R., Lin, H., Andrews, C., et al. (2023) · Cells · doi:10.3390/cells12091254 · Cited by 68
“Macrophages are the most abundant innate immune cells in the lung, and they play an important role in the pathogenesis of pulmonary fibrosis [8,9].”
BackgroundImmunesenescence: A Predisposing Risk Factor for the Development of COVID-19?
Hazeldine, J., & Lord, J. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.573662 · Cited by 67
Li, X., Liu, Y., Tang, Y., & Xia, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1474688 · Cited by 67
“Down-regulating the pro-fi brosis activity of alveolar macrophages or depleting this group of cells can effectively treat experimental PF (181 – 183).”
BackgroundMacrophage Implication in IPF: Updates on Immune, Epigenetic, and Metabolic Pathways
Pokhreal, D., Crestani, B., & Helou, D. G. (2023) · Cells · doi:10.3390/cells12172193 · Cited by 62
CD116+ fetal precursors migrate to the perinatal lung and give rise to human alveolar macrophages
Evren, E., Ringqvist, E. E., Doisne, J., Thaller, A., Sleiers, N., Flavell, R. A., Santo, J. P. D., & Willinger, T. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20210987 · Cited by 62
“…from blood monocytes during aging (Gomez Perdiguero et al., 2015; Liu et al., 2019), infection (Aegerter et al., 2020; Machiels et al., 2017; McCubbrey et al., 2018; Misharin et al., 2017; Mould et al., 2017; Mould et al., 2019), fibrosis (Aran et al., 2019; Joshi et al., 2020;…”
BackgroundMackintosh, J. A., Keir, G. J., Troy, L. K., Holland, A. E., Grainge, C., Chambers, D. C., Sandford, D., Jo, H. E., Glaspole, I., WILSHER, M. L., et al. (2024) · Respirology · doi:10.1111/resp.14656 · Cited by 60
King, E. M., Zhao, Y., Moore, C. M., Steinhart, B., Anderson, K. C., Vestal, B. E., Moore, P. K., McManus, S. A., Evans, C. M., Mould, K. J., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.182700 · Cited by 59
“In mouse models of lung fibrosis, such as the bleomycin model, macrophages have been implicated as central drivers of the fibrotic response (18–21).”
InfluentialSelf-citationRegulation of alveolar macrophage death in pulmonary fibrosis: a review
Yang, G., Yang, Y., Liu, Y., & Liu, X. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01888-4 · Cited by 57
“Mice are protected from bleomycin-induced PF once c-FLIP, an anti-apoptotic protein, is deleted from CD11bhi macrophages [86].”
BackgroundTheobald, H., Bejarano, D. A., Katzmarski, N., Haub, J., Schulte-Schrepping, J., Yu, J., Bassler, K. E., Ament, A. L., Osei-Sarpong, C., Piattini, F., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01830-z · Cited by 56
“Both acute and chronic inflammation induce the recruitment of MoMacs into the bronchoalveolar space 16,31,34 .”
Xu, Q., Mei, S., Nie, F., Zhang, Z., Feng, J., Zhang, J., Qian, X., Gao, Y., He, Z., & Xing, S. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00701-7 · Cited by 55
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes
Fiore, A., Ugel, S., Sanctis, F. D., Sandri, S., Fracasso, G., Trovato, R., Sartoris, S., Solito, S., Mandruzzato, S., Vascotto, F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07654-4 · Cited by 55
Lymphatic Proliferation Ameliorates Pulmonary Fibrosis after Lung Injury
Bałuk, P., Naikawadi, R. P., Kim, S., Rodriguez, F., Choi, D., Hong, Y., Wolters, P. J., & McDonald, D. M. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.08.018 · Cited by 55
Moore, P. K., Anderson, K. C., McManus, S. A., Tu, T.-H. C., King, E. M., Mould, K. J., Redente, E. F., Henson, P. M., Janssen, W. J., & McCubbrey, A. L. (2023) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00223.2022 · Cited by 54
Self-citationRegulation of macrophage activation by lactylation in lung disease
Wei, Y., Guo, H., Chen, S., & Tang, X. X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1427739 · Cited by 53
Cheresh, P., Kim, S.-J., Jablonski, R. P., Watanabe, S., Lu, Z., Chi, M., Helmin, K. A., Gius, D. R., Budinger, G. R. S., & Kamp, D. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136856 · Cited by 53
The Role of TRPV4 in Regulating Innate Immune Cell Function in Lung Inflammation
Scheraga, R. G., Southern, B. D., Grove, L. M., & Olman, M. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01211 · Cited by 52
Alveolar macrophages: Achilles’ heel of SARS-CoV-2 infection
Wang, Z., Li, S., & Huang, B. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01106-8 · Cited by 50
Bordag, N., Biasin, V., Schnoegl, D., Valzano, F., Jandl, K., Nagy, B. M., Sharma, N., Wygrecka, M., Kwapiszewska, G., & Marsh, L. M. (2020) · iScience · doi:10.1016/j.isci.2020.101819 · Cited by 47
Deng, L., Ouyang, B., Tang, W., Wang, N., Yang, F., Shi, H., Zhang, Z., Yu, H., Chen, M., Wei, Y., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155687 · Cited by 44
Sirtuin 2 enhances allergic asthmatic inflammation
Lee, Y. G., Reader, B. F., Herman, D. D., Streicher, A., Englert, J. A., Ziegler, M., Chung, S., Karpurapu, M., Park, G. Y., Christman, J. W., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.124710 · Cited by 44
Developmental mechanisms and adult stem cells for therapeutic lung regeneration
Lee, J., & Rawlins, E. L. (2017) · Developmental Biology · doi:10.1016/j.ydbio.2017.09.016 · Cited by 43
“Similarly, circulating monocytes and macrophages can worsen, or ameliorate, bleomycinmodels of fibrosis depending on the stage of the process (Gibbons et al., 2011; McCubbrey et al., 2017).”
BackgroundUpdate in Pulmonary Fibrosis 2018
Sgalla, G., Kulkarni, T., Antin-Ozerkis, D. E., Thannickal, V. J., & Richeldi, L. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0542up · Cited by 43
The Role of Innate Immunity in Pulmonary Infections
Zhang, H., He, F., Li, P., Hardwidge, P. R., Li, N., & Peng, Y. (2021) · BioMed Research International · doi:10.1155/2021/6646071 · Cited by 41
“Under the pathological conditions of inflammation, injury, and infection, the subgroup of AMs is different in the lung, namely, tissueresident AMs (TR-AMs) and monocyte-derived AMs (MoAMs) [34, 35].”
BackgroundPoole, J. A., Thiele, G. M., Janike, K., Nelson, A. J., Duryee, M. J., Rentfro, K., England, B. R., Romberger, D. J., Carrington, J. M., Wang, D., et al. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3745 · Cited by 39
Advances in single-cell sequencing: insights from organ transplantation
Wang, Y., Wang, J., Schnieke, A., & Fischer, K. (2021) · Military Medical Research · doi:10.1186/s40779-021-00336-1 · Cited by 38
Antifibrotic Drug Nintedanib Inhibits CSF1R to Promote IL-4–associated Tissue Repair Macrophages
Watson, C. K., Schloesser, D., Fundel‐Clemens, K., Lerner, C., Gabler, S., Baskaran, P., Wohnhaas, C. T., Dichtl, S., Huber, H. J., Ask, K., et al. (2023) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2022-0021oc · Cited by 38
Fibroblasts and their responses to chronic injury in pulmonary fibrosis
Wu, B., Tang, L. F., & Kapoor, M. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.12.003 · Cited by 37
Kim, S. H., White, Z., Gainullina, A., Kang, S., Kim, J., Dominguez, J. R., Choi, Y., Cabrera, I., Plaster, M., Takahama, M., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.04.004 · Cited by 37
Choi, S. M., Mo, Y., Bang, J., Ko, Y. G., Ahn, Y. H., Kim, H. Y., Koh, J., Yim, J., & Kang, H. (2023) · Respiratory Research · doi:10.1186/s12931-023-02357-x · Cited by 36
Animal models of rheumatoid arthritis‐associated interstitial lung disease
Xiong, L., Xiong, L., Hong, Y., & Ma, W. (2020) · Immunity Inflammation and Disease · doi:10.1002/iid3.377 · Cited by 34
The role of PD-1/PD-L1 axis in idiopathic pulmonary fibrosis: Friend or foe?
Jiang, A., Liu, N., Wang, J., Zheng, X., Ren, M., Zhang, W., & Yao, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1022228 · Cited by 34
Inhibition of AXL ameliorates pulmonary fibrosis via attenuation of M2 macrophage polarisation
Kim, D. H., Kim, H. C., Im, K., Baek, I.-J., Choi, Y. J., Lee, H., Kim, D.-S., Lee, C. W., Jeong, J., Ban, K., et al. (2025) · European Respiratory Journal · doi:10.1183/13993003.00615-2024 · Cited by 33
Qin, W., Spek, C. A., Scicluna, B. P., van der Poll, T., & Duitman, J. (2022) · Respiratory Research · doi:10.1186/s12931-022-02088-5 · Cited by 33
“CD11bhi alternative macrophages promote the development of bleomycin-induced fibrosis as elegantly shown by the fact that depletion of this specific subset prevents fibrosis [44].”
BackgroundTherapeutic strategies targeting pro-fibrotic macrophages in interstitial lung disease
Isshiki, T., Vierhout, M., Naiel, S., Ali, P., Yazdanshenas, P., Kumaran, V. R., Yang, Z., Dvorkin‐Gheva, A., Rullo, A. F., Kolb, M. R. J., et al. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115501 · Cited by 33
Macrophages and cadherins in fibrosis and systemic sclerosis
To, S., & Agarwal, S. K. (2019) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000657 · Cited by 32
Zhang, Y., Zhang, L., Mao, L., Fan, J., Jiang, X., Li, N., Fan, Y., Jiang, Z., Qin, X., Qiu, F., et al. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0515oc · Cited by 32
de Cevins, C., Delage, L., Batignes, M., Riller, Q., Luka, M., Rémaury, A., Sorin, B., Fali, T., Masson, C., Hoareau‐Coudert, B., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101333 · Cited by 31
Cheresh, P., Kim, S.-J., Huang, L. S., Watanabe, S., Joshi, N., Williams, K. J. N., Chi, M., Lu, Z., Harijith, A. K., Yeldandi, A. V., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165595 · Cited by 30
Auld, S. C., Sheshadri, A., Alexander‐Brett, J. M., Aschner, Y., Barczak, A. K., Basil, M. C., Cohen, K. A., Cruz, C. S. D., McGroder, C. F., Restrepo, M. I., et al. (2024) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202406-651st · Cited by 29
“…leads to an expansion of monocyte-derived interstitial macrophages (37) and alveolar macrophages (MoAMs) (38 – 41), which come into direct contact with fi broblasts in the matrix as they enter the alveolar space (39, 41 – 51) and express factors necessary for fi broblast proliferation (41, 44, 52).”
Integrative analyses of genes associated with idiopathic pulmonary fibrosis
Wang, H., Xie, Q., Ou‐Yang, W., & Zhang, M. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28153 · Cited by 29
Allawzi, A. M., McDermott, I., Delaney, C. A., Nguyen, K. M., Banimostafa, L., Trumpie, A., Hernandez‐Lagunas, L., Riemondy, K. A., Gillen, A. E., Hesselberth, J. R., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901038rr · Cited by 29
Self-citationInhibition of CHIT1 as a novel therapeutic approach in idiopathic pulmonary fibrosis
Sklepkiewicz, P. L., Dymek, B., Mlącki, M., Koralewski, R., Mazur, M., Nejman‐Gryz, P., Korur, S., Zagożdżon, A., Rymaszewska, A., von der Thüsen, J. H., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174792 · Cited by 28
Alveolar macrophages: guardians of the alveolar lipid galaxy
Little, I., Bersie, S. M., Redente, E. F., McCubbrey, A. L., & Tarling, E. J. (2025) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000987 · Cited by 27
“2) [59,60].”
Self-citationBrazee, P. L., Allen, N., Knipe, R. S., Redente, E. F., & Saux, C. J. L. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2649-9402 · Cited by 27
“Methods have ranged from counting cells from the bronchoalveolar lavage (BAL) 11 and fl ow cytometry ( fl uores-cence-activated cell sorting [FACS]) 15 – 17 to more recent single-cell RNA sequencing 12,18,19 techniques.”
Self-citationNOX4 regulates macrophage apoptosis resistance to induce fibrotic progression
Larson‐Casey, J. L., Gu, L., Kang, J., Dhyani, A., & Carter, A. B. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100810 · Cited by 26
“Implicating the importance of macrophages in fibrosis, several studies demonstrated that promoting apoptosis of recruited lung macrophages protects mice from lung fibrosis (9, 10).”
BackgroundKwak, D., Bradley, P. B., Subbotina, N., Ling, S., Teitz‐Tennenbaum, S., Osterholzer, J. J., Sisson, T. H., & Kim, K. K. (2023) · Respiratory Research · doi:10.1186/s12931-023-02629-6 · Cited by 25
“Particularly compelling are several studies that used different approaches to prevent the recruitment of Ly-6C-high monocytes and exudate macrophages into the lung following a fibrotic insult and found that this intervention attenuated scarring [46–48].”
BackgroundPost‐translational regulation of PGC‐1α modulates fibrotic repair
Larson‐Casey, J. L., Gu, L., Davis, D., Cai, G., Ding, Q., He, C., & Carter, A. B. (2021) · The FASEB Journal · doi:10.1096/fj.202100339r · Cited by 24
Isolation and Characterization of Mononuclear Phagocytes in the Mouse Lung and Lymph Nodes
Gibbings, S. L., & Jakubzick, C. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8570-8_3 · Cited by 24
Self-citationTargeting the Myofibroblast in Pulmonary Fibrosis
Misharin, A. V., & Budinger, G. R. S. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201806-1037ed · Cited by 24
Alveolar Macrophages in Viral Respiratory Infections: Sentinels and Saboteurs of Lung Defense
Pöpperl, P., Stoff, M., & Beineke, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26010407 · Cited by 23
“However, functional alterations of these recruited AlvM ϕ can be either beneficial or detrimental for lung homeostasis, host defense, and tissue repair following respiratory infection [63,64,71,72].”
Mizutani, S., Nishio, J., Kondo, K., Motomura, K., Yamada, Z., Masuoka, S., Yamada, S., Muraoka, S., Ishii, N., Kuboi, Y., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14050474 · Cited by 23
“Monocyte-derived alveolar macrophages, but not embryo-derived resident alveolar macrophages, express profibrotic genes in BLM-ILD [16], suggesting that these migrated monocyte-derived alveolar macrophages are responsible for ILD.”
BackgroundInfluential
Metadata
- Authors
- McCubbrey, A. L., Barthel, L., Mohning, M. P., Redente, E. F., Mould, K. J., Thomas, S. M., Leach, S. M., Danhorn, T., Gibbings, S. L., Jakubzick, C. V., Henson, P. M., & Janssen, W. J.
- Affiliations
- University of Colorado Anschutz (US)
- Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, and
- National Jewish Health (US)
- Corresponding author
- McCubbrey, Alexandra L.
- ORCID
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-01-01
- Volume
- 58
- Issue
- 1
- Pages
- 66-78
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- PMC
- PMC5941310
- OpenAlex
- W2750997091
- Cited by
- 195
- References
- 52
- Citations by year
- 2026: 19 · 2025: 30 · 2024: 26 · 2023: 25 · 2022: 24 · 2021: 15 · 2020: 27 · 2019: 15 · 2018: 10
- FWCI
- 12.67
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Respiratory Cell and Molecular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (IK2 BX002401)
- National Institutes of Health (T32 HL0070-85, NIH T32, P 30CA046934)
- National Heart, Lung, and Blood Institute (R35HL140039, F32HL131397, F32HL126333, R01HL109517, R01HL114381, R01HL130938, T32HL007085)
- National Cancer Institute (P30CA046934)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- c-FLIP, idiopathic pulmonary fibrosis, bleomycin-induced lung fibrosis, macrophage apoptosis, monocyte-derived macrophages, alveolar macrophages, Siglec-F, chemokines, growth factors, macrophage depletion
- MeSH terms
- Animals, Bleomycin, Female, Humans, Macrophages, Male, Pulmonary Fibrosis, Gene Deletion, CD11 Antigens, Mice, CASP8 and FADD-Like Apoptosis Regulating Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.